Defective regulation of leukemic hematopoiesis in chronic myeloid leukemia - PubMed (original) (raw)
Review
Defective regulation of leukemic hematopoiesis in chronic myeloid leukemia
C Eaves et al. Leuk Res. 1998 Dec.
Abstract
Over the last two decades considerable knowledge has been acquired about the distribution of cell types within the dominant leukemic (Ph+/BCR-ABL+) clone that results in human chronic myeloid leukemia (CML). Evidence is now growing to indicate that three key biological changes affecting the development of such clones are: (1) an increased probability of differentiation at the level of the most primitive leukemic stem cells; (2) an increased turnover rate of the leukemic progenitors at all stages of differentiation: and (3) their increased ability to survive under conditions of factor-deprivation. Such a model explains the long latent period for the development of CML as well as why normal stem cells may persist in large numbers but still fail to compete in contributing to the daily output of mature blood cells in patients with disease. The recent development of new genetic and transplant models of human CML may now allow the molecular basis of these biological disturbances to be delineated and more effective therapeutic strategies developed.
Similar articles
- The biology of normal and neoplastic stem cells in CML.
Eaves C, Udomsakdi C, Cashman J, Barnett M, Eaves A. Eaves C, et al. Leuk Lymphoma. 1993;11 Suppl 1:245-53. doi: 10.3109/10428199309047894. Leuk Lymphoma. 1993. PMID: 8251904 Review. - Characterization and selection of benign stem cells in chronic myeloid leukemia.
Lemoli RM. Lemoli RM. Haematologica. 1993 Nov-Dec;78(6):393-400. Haematologica. 1993. PMID: 8175034 Review. - Bestatin selectively suppresses the growth of leukemic stem/progenitor cells with BCR/ABL mRNA transcript in patients with chronic myelogeneous leukemia.
Fujisaki T, Otsuka T, Gondo H, Okamura T, Niho Y, Ohhinata A, Abe F. Fujisaki T, et al. Int Immunopharmacol. 2003 Jun;3(6):901-7. doi: 10.1016/S1567-5769(03)00083-3. Int Immunopharmacol. 2003. PMID: 12781706 - [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
Akhlynina TV, Gerasimova LP, Sarkisian GP, Borovkova TV, Dukhovenskaia EA, Manakova TE, Naĭdenova NM, Timofeev AM, Grineva NI. Akhlynina TV, et al. Tsitologiia. 2007;49(10):889-900. Tsitologiia. 2007. PMID: 18074781 Russian.
Cited by
- Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia.
Jiang X, Lopez A, Holyoake T, Eaves A, Eaves C. Jiang X, et al. Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12804-9. doi: 10.1073/pnas.96.22.12804. Proc Natl Acad Sci U S A. 1999. PMID: 10536003 Free PMC article. - Development of BCR-ABL1 Transgenic Zebrafish Model Reproducing Chronic Myeloid Leukemia (CML) Like-Disease and Providing a New Insight into CML Mechanisms.
Zizioli D, Bernardi S, Varinelli M, Farina M, Mignani L, Bosio K, Finazzi D, Monti E, Polverelli N, Malagola M, Borsani E, Borsani G, Russo D. Zizioli D, et al. Cells. 2021 Feb 19;10(2):445. doi: 10.3390/cells10020445. Cells. 2021. PMID: 33669758 Free PMC article. - Activation of apoptosis signaling eliminates CD34+ progenitor cells in blast crisis CML independent of response to tyrosine kinase inhibitors.
Mak DH, Wang RY, Schober WD, Konopleva M, Cortes J, Kantarjian H, Andreeff M, Carter BZ. Mak DH, et al. Leukemia. 2012 Apr;26(4):788-94. doi: 10.1038/leu.2011.285. Epub 2011 Oct 28. Leukemia. 2012. PMID: 22033489 Free PMC article. - Down-Regulation of PU.1 Gene in Pediatric Acute Lymphoblastic Leukemia Patients from South of Iran.
Nakhost B, Nasiri M, Karimi M, Montazeri S. Nakhost B, et al. Int J Hematol Oncol Stem Cell Res. 2019 Jan 1;13(1):20-24. Int J Hematol Oncol Stem Cell Res. 2019. PMID: 31205624 Free PMC article. - Triptolide induces cell death independent of cellular responses to imatinib in blast crisis chronic myelogenous leukemia cells including quiescent CD34+ primitive progenitor cells.
Mak DH, Schober WD, Chen W, Konopleva M, Cortes J, Kantarjian HM, Andreeff M, Carter BZ. Mak DH, et al. Mol Cancer Ther. 2009 Sep;8(9):2509-16. doi: 10.1158/1535-7163.MCT-09-0386. Epub 2009 Sep 1. Mol Cancer Ther. 2009. PMID: 19723894 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous